# Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line

> **NCT03292822** · PHASE1 · COMPLETED · sponsor: **Cairo University** · enrollment: 18 (actual)

## Conditions studied

- Squamous Cell Carcinoma

## Interventions

- **DIETARY_SUPPLEMENT:** Licochalcone A
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT03292822
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-15
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2024-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03292822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03292822, "Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT03292822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*